CCO открытые
[search 0]
Больше

Download the App!

show episodes
 
CCOHS produces monthly podcasts on a wide variety of topics related to workplace health and safety. Each episode is designed to keep you current with information, tips and insights into the health, safety and well-being of working Canadians. Best of all, they’re FREE! Take a listen to an episode of Health and Safety To Go! You can download the audio segment to your computer or MP3 player and listen to it at your own convenience . . . or on the go!
 
The New CCO podcast from Page tells stories that explore the evolution of the CCO. From culture change to digital transformation to corporate purpose, we focus on the issues that matter to today's communications leaders. Page is the world’s premier membership organization for chief communications officers, PR agency CEOs and educators who seek to enrich the profession and improve corporate reputation management.
 
Loading …
show series
 
In this episode, Colleen Kelley, MD, MPH, discusseskey features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development. Presenter: Colleen Kelley, MD, MPH Atlanta, Georgia Colleen Kelley, MD, MPH, has disclosed that she has received funds for rese…
 
During the COVID-19 pandemic, many workers got used to new remote work environments. With workplaces bringing people back in, it’s important to consider possible options. Learn more about hybrid workplaces and how to decide whether this model is right for your organization. Released: September 15, 2021 File Size: 4 MB Length: 6:54 minutes…
 
Pendant la pandémie de COVID-19, de nombreux travailleurs se sont habitués à de nouveaux environnements de travail à distance. Maintenant que les milieux de travail font revenir les gens, il est important d’examiner les options possibles. Apprenez-en davantage sur les milieux de travail hybrides et sur la façon de déterminer si un tel modèle convie…
 
In this second of 2 episodes, Shobha Swaminathan, MD, and Eric S. Daar, MD, review key data influencing their practice following the IAS 2021 Conference, including data on investigational antiretroviral agents, lenacapavir and islatravir, and alternative dosing of BPaL for MDR-TB. This episode includes discussion of: An extension of FLAIR, demonstr…
 
In this podcast episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, and Arthur Kim, MD, discuss data on the potential use of monoclonal antibodies (mAb) for the prevention and treatment of COVID-19, including: Rationale for use of mAb Potential for resistance to mAb Single vs combination therapy with mAb Challenges in implementation of mAb as treatmen…
 
In this first of 2 episodes, Shobha Swaminathan, MD, and Eric S. Daar, MD, review key data influencing their practice following the IAS 2021 Conference, including results from studies on HIV and COVID-19 outcomes; virologic and metabolic outcomes of DTG/3TC; long-acting CAB plus RPV for ART in treatment-naive PWH. This episode includes discussion o…
 
In this series of 3 episodes, Geeta Gupta, MD, discusses strategies for optimizing ART in heavily treatment–experienced patients with HIV, including management of virologic failure and switching ART in virologically suppressed patients with underlying resistance. The 3 episodes will include analyses from: BENCHMRK, which demonstrated that the numbe…
 
In this episode, Mindie H. Nguyen, MD, MAS, AGAF, FAASLD, and Lewis R. Roberts, MB ChB, PhD, examine the HBV burden and care disparities in specific populations, including Asian Americans and foreign-born immigrants, and strategies to address barriers to care. Presenters: Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Professor of Medicine Department of G…
 
In this series of 3 episodes, Geeta Gupta, MD, discusses strategies for optimizing ART in heavily treatment–experienced patients with HIV, including management of virologic failure and switching ART in virologically suppressed patients with underlying resistance. The 3 episodes will include analyses from: BENCHMRK, which demonstrated that the numbe…
 
In this series of 3 episodes, Geeta Gupta, MD, discusses strategies for optimizing ART in heavily treatment–experienced patients with HIV, including management of virologic failure and switching ART in virologically suppressed patients with underlying resistance. The 3 episodes will include analyses from: BENCHMRK, which demonstrated that the numbe…
 
In this episode, Joseph J. Eron, Jr., MD, explores whether weight gain should or should not be a factor in determining initial therapy. Listen as he gives his perspectives on: Weight gain following ART initiation by ARV class and ARV drug Results of the ADVANCE and GEMINI-1 and -2 studies, with exploration of weight, risk of CVD and diabetes BMI ch…
 
In this episode, David Malebranche, MD, MPH, discusses modifying ART in virologically suppressed patients, including switching ART in a patient with daily pill fatigue, switching ART to avoid comorbidities and simplifying ART in the context of known multidrug resistance. The overview will include analyses from: The ATLAS and FLAIR studies in which …
 
In this episode, Paul E. Sax, MD, discusses emerging drug therapies and treatment options for patients with HIV, including rapid initiation of ART, long-acting ART, and 2-drug ART regimens. The overview will include analyses from: The RAPID ART program in San Francisco, where same-day initiation of ART led to faster HIV-1 RNA suppression that was m…
 
In this episode, Jennifer Cocohoba, PharmD, and Jason Schafer, PharmD, MPH, discuss key studies from IAS 2021 that will influence the role of the pharmacist in the treatment and prevention of HIV. Their discussion includes analyses of: The 144-week analysis of the TANGO study, showing high rates of virologic suppression of patients switched from a …
 
In this episode, Babafemi Taiwo, MBBS, discusses new HIV data from IAS 2021, including: WHO Global Clinical Platform: COVID-19 outcomes in PWH 2-drug regimen of DTG/3TC: efficacy, metabolic outcomes (TANGO) Investigational antiretroviral use CAB LA + RPV LA in treatment-naive PWH (FLAIR) Investigational antiretroviral agents LEN (CAPELLA, CALIBRATE…
 
During this episode, Darrell H. S. Tan, MD, FRCPC, PhD, discusses approved and guideline-recommended oral HIV PrEP regimens and provides key insights on determining PrEP candidacy as well as important considerations for specific populations/clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals. Presenter: D…
 
A recent study reported that Canadians spend about 11 hours a day looking at a screen. Extended computer or digital device use can lead to a number of eye and vision problems, headaches, back pain, and sleep issues. Learn more about giving your eyes the break they need. Released: August 12, 2021 File Size: 3.3 MB Length: 5:38 minutes…
 
Selon une étude récente, les Canadiens passent environ 11 heures par jour devant un écran. L’utilisation prolongée d’un ordinateur ou d’un appareil numérique peut entraîner un certain nombre de problèmes oculaires et de vision, des maux de tête, des maux de dos et des troubles du sommeil. Apprenez-en davantage sur la façon de donner à vos yeux la p…
 
In episode 5 of an ongoing series of sharing sessions between a physician and patient, Anna Christina L. dela Cruz, MD, and Rhonda, who is living with chronic hepatitis B, discuss what to do when the decision to start treatment is not clear because of borderline ALT test results and HBV DNA levels. Their conversation highlights a need for patient e…
 
In episode 4 of an ongoing series of sharing sessions between a physician and patient, Geoffrey M. Dusheiko, MD, FCP(SA), FRCP, discusses hepatitis B diagnosis and treatment with his patient, Mark. The conversation focuses on Mark’s missed HBV diagnosis and likely reactivation following treatment for rheumatoid arthritis and raises awareness for ne…
 
In this episode, Oluwaseun Falade-Nwulia, MBBS, MPH, and Joseph K. Lim, MD, examine the HCV burden and care disparities in specific populations, including Black, Hispanic, Asian, American Indian, and Alaska Native persons, and strategies to address barriers to care. Oluwaseun Falade-Nwulia, MBBS, MPH Associate Professor Division of Infectious Disea…
 
In this episode, Stefan Zeuzem, MD, discusses exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure. Stefan Zeuzem, MD Professor of Medicine Chief, Department of Medicine I J…
 
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue worki…
 
In this podcast, Spencer H. Durham, PharmD, BCPS, BCIDP; Stefan Gravenstein, MD, MPH; and Barbara Resnick, PhD, CRNP, discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults. Following their dialogue, the faculty field q…
 
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue worki…
 
In this episode, Jehan Budak, MD, discusses the use of HIV-ASSIST, a free, online, decision-support tool to inform ART selection. Jehan Budak, MD Assistant Professor Division of Allergy & Infectious Diseases University of Washington Seattle, Washington Content based on a CME program supported by educational grants from Gilead Sciences, Inc.; Therat…
 
In this episode, Latesha Elopre, MD, MSPH, explains how to initiate pre-exposure prophylaxis (PrEP), including i underserved communities, with examples on overcoming barriers and improving access. Listen as she gives her perspectives on: Evidence for PrEP efficacy in the DISCOVER study Recommendations in MSM, heterosexual men and women, injection d…
 
In this episode, Daniel J. Kuritzkes, MD, reviews key clinical trial data and gives practical insights such as how to initiate a patient on long-acting therapy, recommended dosing regimens, and factors that may increase the risk of treatment failure. The overview will include analyses of: ATLAS and FLAIR studies of long-acting injectable CAB + RPV …
 
No matter the season or type of work, if staff don't drink enough fluids to replace what is lost in the day, they can become dehydrated. Just a small drop can cause a loss of energy, with severe dehydration being a medical emergency. Learn more about keeping workers safe, including tips for recognition and prevention. Released: July 7, 2021 File Si…
 
Peu importe la saison ou le type de travail, toute personne qui ne boit pas suffisamment de liquides pour remplacer ce qui est perdu durant la journée peut se déshydrater. Même une légère déshydratation peut entraîner une perte d’énergie, et toute déshydratation sévère constitue une urgence médicale. Apprenez en davantage sur la sécurité des travai…
 
In this episode, Joseph J. Eron, Jr., MD, and Darcy Wooten, MD, share insights on HIV antiretroviral therapy safety and tolerability including recent data on weight gain and metabolic implications with INSTIs and NRTIs as well as the latest updates and recommendations on dolutegravir and pregnancy. Joseph J. Eron, Jr., MD Professor of Medicine and …
 
Listen to expert insights from Joseph J. Eron, Jr., MD, on exciting data about investigational agents (dapivirine ring, islatravir, lenacapavir, broadly neutralizing antibodies) for next-generation HIV prevention. Joseph J. Eron, Jr., MD Professor of Medicine and Epidemiology University of North Carolina School of Medicine Director, AIDS Clinical T…
 
Carmella Glover, president of the Diversity Action Alliance and director of DE&I at Page stopped by the podcast for a conversation on what Juneteenth becoming a federal holiday means for all Americans and how business leaders can use this opportunity to help build an equitable future.
 
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue worki…
 
As the world grappled with the hardships of COVID-19, Mark Hoplamazian, President and CEO of Hyatt, struggled balancing his personal grief with the harsh business realities of the pandemic. Leaning into his empathy, Hoplamazian transformed Hyatt’s culture, implementing new policies and technology to support employee mental health and well-being.…
 
Construction workers and those working in jobs with many physical demands may experience injury or pain at a higher rate. Without proper guidance, those who use opioids or other substances to manage this pain may be at an increased risk for experiencing harms. Listen to our podcast conversation with the Canadian Centre on Substance Use and Addictio…
 
In this episode, David A. Wohl, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV. David A. Wohl, MD Professor of Medicine School of Medicine Site Leader, AIDS Clinical Trials Unit-Chapel Hill University of North Carolina at Chapel Hill Director, North Carolina AIDS Tra…
 
In this episode, Roger Bedimo, MD, MS, FACP; Princy N. Kumar, MD, FIDSA, MACP; and Brian Wood, MD, answer healthcare professionals’ most pressing questions on caring for heavily treatment–experienced patients with HIV. Faculty: Roger Bedimo, MD, MS, FACP Professor of Medicine Division of Infectious Diseases University of Texas Southwestern Medical …
 
In this episode, the first in a yearlong series on Key Decisions in HIV Care, Daniel R. Kuritzkes, MD, and Chloe Orkin, MBChB, FRCP, MD, discuss important considerations when switching ART in patients with viral suppression on their current regimen, including guideline recommendations and data supporting different switch regimen options such as sin…
 
Brain injuries can be among the most serious of workplace injuries. To get a better understanding of the impacts on employees, employers, and how to support staff as they return to work, listen to this CCOHS podcast with researchers from the University of Toronto’s Acquired Brain Injury & Society Team. Released: June 4, 2021 File Size: 11 MB Length…
 
Listen to expert insights from W. David Hardy, MD, on current options for pre-exposure prophylaxis and exciting new data on next-generation HIV prevention. W. David Hardy, MD Scientific and Medical Consultant Adjunct Clinical Professor of Medicine Division of Infectious Diseases Keck School of Medicine of USC Los Angeles, California Content based o…
 
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue worki…
 
In this episode, Daniel R. Kuritzkes, MD, and Michelle S. Cespedes, MD, MS, discuss new ART data from virtual CROI 2021. Michelle S. Cespedes, MD, MS Associate Professor of Medicine Division of Infectious Disease Department of Medicine Icahn School of Medicine at Mount Sinai Attending Physician Mount Sinai Medical Center New York, New York Daniel R…
 
In this episode, Ethel D. Weld, MD, PhD, demonstrates the use of HIV-ASSIST, a free, online, decision support tool to inform ART selection. Ethel D. Weld, MD, PhD Assistant Professor of Medicine, Pharmacology, & Molecular Sciences Division of Clinical Pharmacology Department of Infectious Diseases Johns Hopkins University School of Medicine Attendi…
 
In episode 3 of an ongoing series of sharing sessions between a physician and patient, Jordan J. Feld, MD, MPH, and Wendy, who is living with chronic hepatitis B, discuss the challenges of determining the best time to start treatment. The conversation focuses on incorporating shared decision-making, particularly for cases that are not straight forw…
 
In this episode, William R. Short, MD, MPH, AAHIVS, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV. William R. Short, MD, MPH, AAHIVS Associate Professor of Medicine Division of Infectious Diseases Department of Medicine Perelman School of Medicine at the University of P…
 
Workplaces have a duty to protect employees on the job, and part of that commitment includes having a current health and safety program in place. Learn more about the basics of a program, what’s required by law, and how to ensure it’s making a positive impact on your workers. Released: May 6, 2021 File Size: 4.6 MB Length: 8:12 minutes ---------- >…
 
In Part 4 of this 4-part series, listen to Howard Grossman, MD, and Cristina Mussini, MD, answer healthcare professionals’ questions on vaccine recommendations, bone health and fragility fractures, and racial disparities and social determinants that affect caring for patients aging with HIV. Presenters: Howard Grossman, MD Clinical Affiliate Assist…
 
In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss simplification strategies for a virologically suppressed patient with HIV and a complex ART treatment history. Presenters: José R. Arribas, MD Research Director, HIV and Infectious Diseases Hospital La Paz IdiPAZ Madrid, Spain Andrew Carr, MBBS, MD, FRACP, FRCPA Professo…
 
In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss ART safety and management in a woman who wishes to conceive. Presenters: José R. Arribas, MD Research Director, HIV and Infectious Diseases Hospital La Paz IdiPAZ Madrid, Spain Andrew Carr, MBBS, MD, FRACP, FRCPA Professor of Medicine University of New South Wales Direct…
 
Loading …

Краткое руководство

Google login Twitter login Classic login